Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza

Open Access

Peer-reviewed

Research Article

Jianfeng Zhang,

Affiliation Vaxin, Inc., Birmingham, Alabama, United States of America
⨯
E. Bart Tarbet,

Affiliation Institute for Antiviral Research, Utah State University, Logan, Utah, United States of America
⨯
Tsungwei Feng,

Affiliation Vaxin, Inc., Birmingham, Alabama, United States of America
⨯
Zhongkai Shi,

Affiliation Vaxin, Inc., Birmingham, Alabama, United States of America
⨯
Kent R. Van Kampen,

Affiliation Vaxin, Inc., Birmingham, Alabama, United States of America
⨯
De-chu C. Tang

* E-mail: dechutang@gmail.com

Affiliation Vaxin, Inc., Birmingham, Alabama, United States of America
⨯

Reader Comments (0)

Influenza
Is the Subject Area "Influenza" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Prophylaxis
Is the Subject Area "Prophylaxis" applicable to this article?

Thanks for your feedback.
Influenza A virus
Is the Subject Area "Influenza A virus" applicable to this article?

Thanks for your feedback.
Lung resection
Is the Subject Area "Lung resection" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.